Drug intelligence / Profile preview

Xue Zhi Ning Pill

Development stage
Unknown
Lead developer
Tianjin Pharmaceutical Da Ren Tang Group
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Xue Zhi Ning Pill (also known as Xuezhining Pill or Xuezhining Wan) is a traditional Chinese medicine (TCM) formula developed and manufactured by Jinsheng Da Ren Tang (Tianjin Pharmaceutical Da Ren Tang Group). It is approved in China for the treatment of hyperlipidemia, particularly of the phlegm-turbidity obstruction type, with symptoms such as dizziness, chest tightness, and constipation. The formula consists of four main active herbal ingredients: Cassia Seed (Semen Cassiae), Hawthorn (Fructus Crataegi), Lotus Leaf (Folium Nelumbinis), and Prepared Polygonum multiflorum (Radix Polygoni Multiflori Praeparata). These components work synergistically to lower blood lipid levels, improve lipid metabolism, and promote bowel movements.

Brand names
Xue Zhi Ning Pill
Other names
Xuezhining PillXuezhining Wan血脂宁丸

Beyond the preview

Go deeper on Xue Zhi Ning Pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xue Zhi Ning Pill.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call